Registry tracks endoscopic treatments for weight loss in adults with obesity
Collects data on endoscopic weight-loss treatments in adults with obesity over time.
Key facts
- Who runs it
- Weill Medical College of Cornell University
- Where
- New York, United StatesSee the site
- Trial code
- Registry title
- Endoscopic Bariatric Therapies (EBTs): A Retrospective and Prospective Multicenter Registry
- Status
- Recruiting
- People taking part
- 9,999 people, planned
- Started
- 5 Apr 2016
- Expected to end
- 31 Oct 2035
- Type of study
- Observational
- Treatments tested
- Endoscopic Bariatric Therapies
- Record updated
- 23 April 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who are thinking about endoscopic weight-loss treatment within 6 months, or who had it in the past 6 months.
- Age
- 18 Years to 89 Years
- Sex
- All sexes can join.
- Earlier treatment
- People can join if they plan to have, or already had in the last 6 months, an endoscopic bariatric therapy (EBT) for weight loss.
Main reasons for not taking part
- Has not had and will not have an endoscopic weight-loss treatment (EBT)
- Younger than 18 years
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Any patient who is considering undergoing EBT for weight loss within 6 months, or has undergone clinically indicated EBT for weight loss within the past 6 months
- Above or equal to 18 years of age
Who cannot take part
- Below 18 years of age
- Any patient who has not undergone or will undergo EBT for weight loss
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 89 years old?
Where in United States
- Weill Cornell MedicineNew York, United StatesContact: Reem Z Sharaiha, MDTaking people
About the trial
What the trial wants to find out
The purpose of this registry study is to collect data through medical chart review and in patient visits on the efficacy and safety of various Endoscopic Bariatric therapies (EBTs). This is a retrospective and prospective, observational, medical chart review study for at least 6 standard of care visits up to 1 years after a subject consents for study participation.
The group in the trial
- Endoscopic Bariatric Therapies (EBT).
patients undergoing Endoscopic Bariatric Therapies
Treatment: Endoscopic Bariatric Therapies
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Endoscopic Bariatric Therapies (EBTs): A Retrospective and Prospective Multicenter Registry
- Plain-language title
- Registry tracks endoscopic treatments for weight loss in adults with obesityGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT04494048, who can take part
- Publications
- Improvement in obesity-related comorbidities 5 years after endoscopic sleeve gastroplasty: a prospective cohort study.Gastrointestinal endoscopy, 2025
- Record updated
- 23 April 2026